A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CE / carboplatin and etoposide

[Related PubMed/MEDLINE]
Total Number of Papers: 29
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CE  (>> Co-occurring Abbreviation)
Long Form:   carboplatin and etoposide
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era. ASCT, GCTs, HDCT
2019 Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study. ES-SCLC, HR, PFS, SCLC
2018 A case of cisplatin-refractory advanced pure seminoma showing complete remission after treatment with high-dose carboplatin plus etoposide as fourth-line salvage chemotherapy. CR
2018 Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status. AMR, ED-SCLC, PS
2017 A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer. CI, HR
2017 Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study. CTCs, ED-SCLC, OS, PFS
2016 Refractory Small Cell Carcinoma of the Ovary - Hypercalcemic Type (SCCOHT) Treated with Romidepsin and Topotecan: A Case Report and Review of the Literature. HDAC, SCCOHT, SCLC
2015 Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors. ASCT, CR, HD, MTD, TIC
2014 Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies. AEs, CT, GE, IGF-1R, PB
10  2011 Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis. CHT, Gy, OS, TRT
11  2011 [High-dose chemotherapy and residual tumor resection in male germ cell tumors]. HDCT
12  2010 [Evaluation of chemotherapy, especially combined therapy with Carboplatin Plus Etoposide(CE), in patients aged > or =80 years old with extensive-disease small-cell lung cancer]. ED-SCLC
13  2009 Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease" stage. CI, G-CSF, SCLC
14  2006 Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors. ---
15  2006 Preliminary individualized chemotherapy for malignant astrocytomas based on O6-methylguanine-deoxyribonucleic acid methyltransferase methylation analysis. PAV
16  2006 Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach. CAV, OS, PCI, PFS, SCLC
17  2006 [Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients]. MIC, NSCLC
18  2004 Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. AA, GBM
19  2003 [Treatment of malignant lymphoma by autologous hematopoietic stem cell transplantation combined with high dose radiotherapy and chemotherapy]. ABMT, AHSCT, APBSCT, G-CSF, GM-CSF, HD, ML, NHL, TBI
20  2001 A randomized Phase II trial in patients with carcinoma of an unknown primary site. CUP
21  2001 Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer. HF, IFI, KPS, RT
22  2001 Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Societe Francaise d'Oncologie Pediatrique. EFS, NB, OS
23  2001 [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients]. ABMT, AHSCT, APBSCT, DFS, HD, ML, NHL, TBI
24  2000 Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer. GC, NSCLC
25  2000 [Local chemotherapy by fibrobronchoscopy for advanced bronchogenic carcinoma]. ---
26  1999 Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study. CHT, CR, CR/CR, MST, PR
27  1998 Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique (SFOP). CAdO, EFS, LN, NBs, NMA, OS, RR, SFOP
28  1997 Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study. MTTP, PR, ST
29  1992 Cardiac tamponade resulting from recurrent small-cell carcinoma of the uterine cervix temporarily responding to CE/CAV chemotherapy: report of a case. CAV